Eckhardt SG - Search Results

1

Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.

Saltz LB, Rosen LS, Marshall JL, Belt RJ, Hurwitz HI, Eckhardt SG, Bergsland EK, Haller DG, Lockhart AC, Rocha Lima CM, Huang X, DePrimo SE, Chow-Maneval E, Chao RC, Lenz HJ. Saltz LB, et al. Among authors: eckhardt sg. J Clin Oncol. 2007 Oct 20;25(30):4793-9. doi: 10.1200/JCO.2007.12.8637. J Clin Oncol. 2007. PMID: 17947727 Clinical Trial.

2

Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.

Abou-Alfa GK, Letourneau R, Harker G, Modiano M, Hurwitz H, Tchekmedyian NS, Feit K, Ackerman J, De Jager RL, Eckhardt SG, O'Reilly EM. Abou-Alfa GK, et al. Among authors: eckhardt sg. J Clin Oncol. 2006 Sep 20;24(27):4441-7. doi: 10.1200/JCO.2006.07.0201. J Clin Oncol. 2006. PMID: 16983112 Clinical Trial.

3

Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program.

Lieu CH, Renfro LA, de Gramont A, Meyers JP, Maughan TS, Seymour MT, Saltz L, Goldberg RM, Sargent DJ, Eckhardt SG, Eng C; Aide et Recherche en Cancérologie Digestive Foundation. Lieu CH, et al. Among authors: eckhardt sg. J Clin Oncol. 2014 Sep 20;32(27):2975-84. doi: 10.1200/JCO.2013.54.9329. J Clin Oncol. 2014. PMID: 25002720 Free PMC article.

4

A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors.

Leong S, Eckhardt SG, Chan E, Messersmith WA, Spratlin J, Camidge DR, Diab S, Khosravan R, Lin X, Chow Maneval E, Lockhart AC. Leong S, et al. Among authors: eckhardt sg. Cancer Chemother Pharmacol. 2012 Jul;70(1):65-74. doi: 10.1007/s00280-012-1880-4. Epub 2012 May 24. Cancer Chemother Pharmacol. 2012. PMID: 22623210 Free PMC article. Clinical Trial.

5

Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups.

O'Dwyer PJ, Eckhardt SG, Haller DG, Tepper J, Ahnen D, Hamilton S, Benson AB 3rd, Rothenberg M, Petrelli N, Lenz HJ, Diasio R, DuBois R, Sargent D, Sloan J, Johnson CD, Comis RL, O'Connell MJ; Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups. O'Dwyer PJ, et al. Among authors: eckhardt sg. J Clin Oncol. 2007 Jun 1;25(16):2313-21. doi: 10.1200/JCO.2006.08.6900. J Clin Oncol. 2007. PMID: 17538178 Review.

6

Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial results.

Patt YZ, Lee FC, Liebmann JE, Diamandidis D, Eckhardt SG, Javle M, Justice GR, Keiser W, Salvatore JR, Bexon A, Lin E. Patt YZ, et al. Among authors: eckhardt sg. Am J Clin Oncol. 2007 Aug;30(4):350-7. doi: 10.1097/COC.0b013e31804b40bb. Am J Clin Oncol. 2007. PMID: 17762434 Clinical Trial.

7

Phase I dose-escalation trial of the oral investigational Hedgehog signaling pathway inhibitor TAK-441 in patients with advanced solid tumors.

Goldman J, Eckhardt SG, Borad MJ, Curtis KK, Hidalgo M, Calvo E, Ryan DP, Wirth LJ, Parikh A, Partyka J, Faessel H, Gangolli E, Stewart S, Rosen LS, Bowles DW. Goldman J, et al. Among authors: eckhardt sg. Clin Cancer Res. 2015 Mar 1;21(5):1002-9. doi: 10.1158/1078-0432.CCR-14-1234. Epub 2014 Dec 12. Clin Cancer Res. 2015. PMID: 25501576 Clinical Trial.

8

Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors.

Holden SN, Eckhardt SG, Basser R, de Boer R, Rischin D, Green M, Rosenthal MA, Wheeler C, Barge A, Hurwitz HI. Holden SN, et al. Among authors: eckhardt sg. Ann Oncol. 2005 Aug;16(8):1391-7. doi: 10.1093/annonc/mdi247. Epub 2005 May 19. Ann Oncol. 2005. PMID: 15905307 Free article. Clinical Trial.

9

A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers.

Abou-Alfa GK, Rowinsky EK, Patt YZ, Schwartz GK, Kelsen DP, Sharma S, Siegel E, Becerra CR, Eckhardt SG, Feit K, De Jager R, O'Reilly EM. Abou-Alfa GK, et al. Among authors: eckhardt sg. Am J Clin Oncol. 2005 Aug;28(4):334-9. doi: 10.1097/01.coc.0000158829.63542.2c. Am J Clin Oncol. 2005. PMID: 16062073 Clinical Trial.

10

Sunitinib: from rational design to clinical efficacy.

Chow LQ, Eckhardt SG. Chow LQ, et al. Among authors: eckhardt sg. J Clin Oncol. 2007 Mar 1;25(7):884-96. doi: 10.1200/JCO.2006.06.3602. J Clin Oncol. 2007. PMID: 17327610 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page